Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 08, 2016 11:40 PM ET

Life Sciences Tools and Services

Company Overview of RainDance Technologies, Inc.

Company Overview

RainDance Technologies, Inc. develops, manufactures, and sells proprietary systems, consumables, and assays that enable ultra-sensitive detection and analysis of complex genetic diseases in tissue and liquid biopsies in life science and translational research settings. The company offers ThunderStorm system that generates one million unique droplet-based single molecule polymerase chain reaction reactions for approximately 20,000 targeted genetic loci, or specific regions of the genome; and provides sensitivity, accuracy, genomic coverage, and uniformity to commercial service laboratories. It also offers ThunderBolts system that provides predefined assays, or primers that target genetic regi...

749 Middlesex Turnpike

Billerica, MA 01821

United States

Founded in 2004

104 Employees





Key Executives for RainDance Technologies, Inc.

Chief Executive Officer, President and Director
Age: 38
Co-Founder and Chief Technology Officer
Age: 46
Chief Financial Officer
Age: 61
Compensation as of Fiscal Year 2015.

RainDance Technologies, Inc. Key Developments

RainDance Technologies, Inc. and Blood Systems Research Institute Collaborate to Develop Ultra-Sensitive Assays to Detect and Quantify HIV Latency

RainDance Technologies, Inc. and Blood Systems Research Institute announced a research collaboration to develop blood-based assays and protocols for the precise measurement of the human immunodeficiency virus (HIV) latent reservoir using RainDance’s RainDrop Digital PCR and ThunderBolts Next-Generation Sequencing (NGS) Enrichment Systems. As part of this collaboration, BSRI will provide access to the RainDance products to key thought leaders at the new amfAR Institute for HIV Cure Research, an innovative collaborative enterprise focused on developing and validating new approaches that can ultimately lead to a functional cure for HIV. Built on RainDance’s unified picodroplet platform, the RainDrop and ThunderBolts Systems generate millions of individual droplet-based tests per sample, providing the dynamic range and quantitation essential for massively-parallel yet precise single molecule analysis. The collaboration between RainDance and BSRI aims to develop ultra-sensitive, highly precise and low cost NGS and digital PCR methods to detect, measure and monitor replication competent latent HIV with absolute quantitation from limited amounts of bio-available fluids.

RainDance Technologies, Inc. Appoints Kathy Ordonez as the Chairman of the Board of Directors

RainDance Technologies, Inc. announced the appointment of Kathy Ordoez as chairman of its board of directors. Ms. Ordoez brings more than 30 years of experience in the life sciences and diagnostics industries, and has served on the board of directors since 2014, and as the chair of the board’s science and innovation committee. As senior vice president at Quest Diagnostics, Kathy Ordoez was responsible for leading the company's businesses in diagnostic products, insurer services, clinical trials and healthcare information technology products and also led research and development. Ordoez was previously the chief executive officer at Celera and a founder of Celera Diagnostics.

Pacific Biosciences of California, Inc. and RainDance Technologies, Inc. Partner to Co-Develop and Commercialize Novel Solution For de novo Whole Genome Assembly

Pacific Biosciences of California, Inc. and RainDance Technologies, Inc. announced their entry into a co-development and co-marketing agreement to commercialize novel solutions for de novo whole genome assembly. These solutions will combine the power of RainDance's proprietary digital droplet technology and single-molecule barcoding capabilities with Pacific Biosciences' proprietary long-range DNA amplification technology to provide sample preparation upstream of PacBio's long-read sequencing system. This combination could provide a method to generate millions of long, single-molecule barcoded DNA fragments, averaging 10-30 kilobases that originated from much longer (100 kilobase) fragments. Combining this fragmentation and labeling scheme with a sequence context-unbiased amplification method for long DNA fragments, PacBio sequencing could provide de novo, haplotype-phased assembly of complex genomes. This would be possible even in genomic regions containing complex repeats or PCR-challenged sequences that limit performance of synthetic long-read approaches based upon short-read sequencing technologies. Furthermore, this approach will be designed to work with low DNA input as little as 1 ng to address scarce or difficult-to-procure samples.

Similar Private Companies By Industry

Company Name Region
ATS Laboratories, Inc. United States
Catalyst Pharma Group, Inc. United States
Cardiovascular Innovation Institution United States
AbCRO, Inc. United States
GenePro Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RainDance Technologies, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at